Bleeding in Liver Surgery: Prevention and Treatment

Clinics in Liver Disease

Volumn 13, Issue 1, 2009, Pages 145-154

  Alkozai, Edris M ^a   Lisman, Ton ^a   Porte, Robert J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Aprotinin; Blood loss; Central venous pressure; Fibrin sealants; Liver resection; Liver transplantation; Surgical methods; Tranexamic acid

Indexed keywords

ANTIFIBRINOLYTIC AGENT; APROTININ; FIBRIN GLUE; FRESH FROZEN PLASMA; HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID;

ARTERY CLAMP; BLOOD TRANSFUSION; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; CLIP; HUMAN; LIVER HEMORRHAGE; LIVER RESECTION; LIVER SURGERY; LIVER TRANSPLANTATION; PHLEBOTOMY; REVIEW; SURGICAL TECHNIQUE; VASODILATATION;

ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD LOSS, SURGICAL; FIBRIN TISSUE ADHESIVE; HEMOSTATICS; HEPATECTOMY; HUMANS; INTRAOPERATIVE COMPLICATIONS; LIVER DISEASES; LIVER TRANSPLANTATION; MONITORING, INTRAOPERATIVE; TRANEXAMIC ACID;

EID: 58149345569     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2008.09.012     Document Type: Review

References (59)

1. Hendriks H.G., van der M.J., De Wolf J.T., et al. Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation. Transpl Int 17 (2005) 673-679
2. Cacciarelli T.V., Keeffe E.B., Moore D.H., et al. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg 134 (1999) 25-29
3. Stainsby D., Williamson L., Jones H., et al. 6 Years of shot reporting-its influence on UK blood safety. Transfus Apheresis Sci 31 (2004) 123-131
4. de Boer M.T., Molenaar I.Q., Hendriks H.G., et al. Minimizing blood loss in liver transplantation: progress through research and evolution of techniques. Dig Surg 22 (2005) 265-275
5. Porte R.J., Hendriks H.G., and Slooff M.J. Blood conservation in liver transplantation: the role of aprotinin. J Cardiothorac Vasc Anesth 18 (2004) 31S-37S
6. Ramos E., Dalmau A., Sabate A., et al. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl 9 (2003) 1320-1327
7. Marietta M., Facchini L., Pedrazzi P., et al. Pathophysiology of bleeding in surgery. Transplant Proc 38 3 (2006) 812-814 Ref Type: Hearing
8. Porte R.J., Knot E.A., and Bontempo F.A. Hemostasis in liver transplantation. Gastroenterology 97 (1989) 488-501
9. Lisman T., and Leebeek F.W. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg 24 (2007) 250-258
10. Findlay J.Y., and Rettke S.R. Poor prediction of blood transfusion requirements in adult liver transplantations from preoperative variables. J Clin Anesth 12 (2000) 319-323
11. Steib A., Freys G., Lehmann C., et al. Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anaesth 48 (2001) 1075-1079
12. Lodge J.P., Jonas S., Oussoultzoglou E., et al. Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology 102 (2005) 269-275
13. Planinsic R.M., van der M.J., Testa G., et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 11 (2005) 895-900
14. Groenland T.H., and Porte R.J. Antifibrinolytics in liver transplantation. Int Anesthesiol Clin 44 (2006) 83-97
15. Friedman L.S. The risk of surgery in patients with liver disease. Hepatology 29 (1999) 1617-1623
16. Suman A., and Carey W.D. Assessing the risk of surgery in patients with liver disease. Cleve Clin J Med 73 (2006) 398-404
17. van Gulik T.M., de G.W., Dinant S., et al. Vascular occlusion techniques during liver resection. Dig Surg 24 (2007) 274-281
18. Smyrniotis V., Farantos C., Kostopanagiotou G., et al. Vascular control during hepatectomy: review of methods and results. World J Surg 29 (2005) 1384-1396
19. Dixon E., Vollmer Jr. C.M., Bathe O.F., et al. Vascular occlusion to decrease blood loss during hepatic resection. Am J Surg 190 (2005) 75-86
20. van der Bilt J.D., Livestro D.P., Borren A., et al. European survey on the application of vascular clamping in liver surgery. Dig Surg 24 (2007) 423-435
21. Nakajima Y., Shimamura T., Kamiyama T., et al. Control of intraoperative bleeding during liver resection: analysis of a questionnaire sent to 231 Japanese hospitals. Surg Today 32 (2002) 48-52
22. Selzner N., Rudiger H., Graf R., et al. Protective strategies against ischemic injury of the liver. Gastroenterology 125 (2003) 917-936
23. Takayama T., Makuuchi M., Kubota K., et al. Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg 136 (2001) 922-928
24. Lesurtel M., Selzner M., Petrowsky H., et al. How should transection of the liver be performed?: a prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann Surg 242 (2005) 814-822 [discussion]
25. Lisman T., Caldwell S.H., Porte R.J., et al. Consequences of abnormal hemostasis tests for clinical practice. J Thromb Haemost 4 (2006) 2062-2063
26. Massicotte L., Sassine M.P., Lenis S., et al. Transfusion predictors in liver transplant. Anesth Analg 98 (2004) 1245-1251 table
27. Ozier Y., Pessione F., Samain E., et al. Institutional variability in transfusion practice for liver transplantation. Anesth Analg 97 (2003) 671-679
28. Kang Y., and Audu P. Coagulation and liver transplantation. Int Anesthesiol Clin 44 (2006) 17-36
29. Lopez-Plaza I. Transfusion guidelines and liver transplantation: time for consensus. Liver Transpl 13 (2007) 1630-1632
30. Melendez J.A., Arslan V., Fischer M.E., et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 187 (1998) 620-625
31. Smyrniotis V., Kostopanagiotou G., Theodoraki K., et al. The role of central venous pressure and type of vascular control in blood loss during major liver resections. Am J Surg 187 (2004) 398-402
32. Jones R.M., Moulton C.E., and Hardy K.J. Central venous pressure and its effect on blood loss during liver resection. Br J Surg 85 (1998) 1058-1060
33. Bismuth H., Castaing D., and Garden O.J. Major hepatic resection under total vascular exclusion. Ann Surg 210 (1989) 13-19
34. Schroeder R.A., Collins B.H., Tuttle-Newhall E., et al. Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesth 18 (2004) 438-441
35. Massicotte L., Lenis S., Thibeault L., et al. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 12 (2006) 117-123
36. Wang W.D., Liang L.J., Huang X.Q., et al. Low central venous pressure reduces blood loss in hepatectomy. World J Gastroenterol 12 (2006) 935-939
37. Hashimoto T., Kokudo N., Orii R., et al. Intraoperative blood salvage during liver resection: a randomized controlled trial. Ann Surg 245 (2007) 686-691
38. Porte R.J., and Leebeek F.W. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs 62 (2002) 2193-2211
39. Berrevoet F., and de H.B. Use of topical hemostatic agents during liver resection. Dig Surg 24 (2007) 288-293
40. Heaton N. Advances and methods in liver surgery: haemostasis. Eur J Gastroenterol Hepatol 17 Suppl 1 (2005) S3-S12
41. Chapman W.C., Clavien P.A., Fung J., et al. Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial. Arch Surg 135 (2000) 1200-1204
42. Schwartz M., Madariaga J., Hirose R., et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 139 (2004) 1148-1154
43. Jackson M.R. Fibrin sealants in surgical practice: an overview. Am J Surg 182 (2001) 1S-7S
44. Carless P.A., Henry D.A., and Anthony D.M. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. Cochrane Database Syst Rev 1 (2003) CD004171
45. Figueras J., Llado L., Miro M., et al. Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients. Ann Surg 245 (2007) 536-542
46. Xia V.W., and Steadman R.H. Antifibrinolytics in orthotopic liver transplantation: current status and controversies. Liver Transpl 11 (2005) 10-18
47. Ozier Y., and Schlumberger S. Pharmacological approaches to reducing blood loss and transfusions in the surgical patient. Can J Anaesth 53 (2006) S21-S29
48. Henry D.A., Carless P.A., Moxey A.J., et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 4 (2007) CD001886
49. Dalmau A., Sabate A., Acosta F., et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg 91 (2000) 29-34
50. Molenaar I.Q., Warnaar N., Groen H., et al. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant 7 (2007) 185-194
51. Warnaar N., Mallett S.V., de Boer M.T., et al. The impact of aprotinin on renal function after liver transplantation: an analysis of 1,043 patients. Am J Transplant 7 (2007) 2378-2387
52. Lentschener C., Benhamou D., Mercier F.J., et al. Aprotinin reduces blood loss in patients undergoing elective liver resection. Anesth Analg 84 (1997) 875-881
53. Wu C.C., Ho W.M., Cheng S.B., et al. Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy. Ann Surg 243 (2006) 173-180
54. Pereboom I.T., de Boer M.T., Porte R.J., et al. Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss. Dig Surg 24 (2007) 282-287
55. Lodge J.P., Jonas S., Jones R.M., et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 11 (2005) 973-979
56. Hendriks H.G., Meijer K., de Wolf J.T., et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation 71 (2001) 402-405
57. Meijer K., Hendriks H.G., de Wolf J.T., et al. Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis. Blood Coagul Fibrinolysis 14 (2003) 169-174
58. Vincent J.L., Rossaint R., Riou B., et al. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding-a European perspective. Crit Care 10 4 (2006) R120
59. Levy J.H., Fingerhut A., Brott T., et al. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion 46 (2006) 919-933